Newswire (Published: Tuesday, April 18, 2017, Received: Friday, April 14, 2017, 7:00:12 AM CDT)

Word Count: 499

Studies in the Area of Prostate Cancer Reported from Wayne State University (Active surveillance for low-risk localized prostate cancer: what do men and their partners think?)

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating in Detroit, Michigan, by NewsRx journalists, research stated, "Active surveillance (AS) is recognized as a reasonable treatment option for low-risk localized prostate cancer (LPC) but continues to be chosen by a minority of men. To date, limited data are available regarding reasons why men with low-risk LPC adopt AS."

Financial support for this research came from American Cancer Society (see also Oncology - Prostate Cancer).

The news reporters obtained a quote from the research from Wayne State University, "The aim of this study is to better understand conceptualizations, experiences and reasons why men with low-risk LPC and their partners adopt AS. We conducted five focus groups (FGs), three among men with low-risk LPC who had chosen AS and two with their partners. FGs were video/audio recorded, transcribed and analysed using qualitative thematic analysis. A total of 12 men and 6 partners (all women) participated in FG discussions. The most common reasons for choosing AS were seeing the LPC as 'small' or 'low grade' without need for immediate treatment and trusting their physician's AS recommendation. The most common concerns about AS were perceived unreliability of prostate specific antigen, pain associated with prostate biopsies and potential cancer progression. Partners saw themselves as very involved in their husbands' treatment decision-making process, more than men acknowledged them to be. Multiple terms including 'watchful waiting' were used interchangeably with AS. There appeared to be a lack of understanding that AS is not simply 'doing nothing' but is actually a recognized management option for low-risk LPC. Emphasizing the low risk of a man's LPC and enhancing physician trust may increase acceptability of AS."

According to the news reporters, the research concluded: "Standardizing terminology and presenting AS as a reasonable and recognized management option may also help increase its adoption."

For more information on this research see: Active surveillance for low-risk localized prostate cancer: what do men and their partners think? Family Practice, 2017;34(1):90-97. Family Practice can be contacted at: Oxford Univ Press, Great Clarendon St, Oxford OX2 6DP, England. (Oxford University Press - www.oup.com/; Family Practice - fampra.oxfordjournals.org)

Our news correspondents report that additional information may be obtained by contacting J.P. Xu, Wayne State University, Dept. of Family Med & Public Hlth Sci, Detroit, MI 48201, United States. Additional authors for this research include J. Ruterbusch, E. Reamer, S. Eggly and J.P. Xu.

Keywords for this news article include: Detroit, Michigan, United States, North and Central America, Cancer, Epidemiology, Prostatic Neoplasms, Prostate Cancer, Oncology, Wayne State University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

Wayne State University
American Cancer Society Inc.
Oxford University Press LLC

Places

Central America
North America
Northern Europe
United Kingdom
United States
Americas
Europe
England
Michigan
Detroit

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer